Glenmark will launch Fabiflu 400 mg tablet for Corona patients

Aug 07 2020 12:39 AM
Glenmark will launch Fabiflu 400 mg tablet for Corona patients

New Delhi: Indian pharmaceutical manufacturer Glenmark Pharmaceuticals is preparing to launch more tablets of its medicine FabiFlu in the market to be used in the treatment of Corona epidemic. The company said that these tablets will be 400 mg. Till now the company was providing 200 mg tablets. This tablet of Glenmark is being used in the treatment of patients with mild symptoms of corona. However, the company has not given any information regarding the price of 400 mg tablet.

Glenmark has said that after the launch of the 400mg tablet, Corona's patients will get rid of the hassle of taking the drug again and again. Patients will get full dose in less pills. According to the company, the corona patient will have to take 9 tablets twice in its first day. After this, from the second day till the completion of the course, only 2 tablets have to be taken twice a day. Glenmark is the first pharmaceutical company in the country, which has received approval from the Drugs Controller General of India to launch tablets in 400mg.

Glenmark Pharmaceuticals launched the antiviral drug Favipiravir under the brand name Fabiflu for the treatment of patients suffering from coronavirus. The Mumbai-based company got the approval for the manufacturing and marketing of this drug from DGCI. On giving information about the company's Vice President and head of clinical development, Monica Tandon said that now the company has made a 400mg tablet under its Research Aid Development Program.

Also Read-

Market rises after decisions made by RBI, Sensex crosses 38 thousand

Will employees of companies like OLA-UBER and Zomato get pension?

RBI changes rules regarding clearing of cheque of more than 50 thousand rupees